Aarkstore.com announces 10% Discount on this report till 30th April 2012
Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing http://www.aarkstore.com/reports/Manufacturing- of-Vaccines-CellCulture- Technology-Gradually- Replacing-Egg-Based-Manufacturing155027.html
RSS Link
Discount offer till 30th April 2012
Summary Company Research, the leading businessintelligence provider, has released its latest research report, “Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-BasedManufacturing�, which provides insights into the production methods of vaccines and into vaccine production capacity. The report discussesthe egg-based and cell culture-based vaccine manufacturing processesin depth. Furthermore, details of the whole processthroughput and the technologies used in vaccine manufacturing are provided in the report. It also offers a clear view of the regulatory landscapesof the US, Europe and Japan. It includes profiles of the key players and the alliances which exist in the world of vaccine manufacturing. The report
explores the emerging technologies, drivers and barriers of the vaccine manufacturing processand the challenges and unmet needs present in the market.
Scope The report analysesvaccine manufacturing processes,market characterization, the regulatory landscape and the current scenario of the vaccine manufacturing industry. The report covers the following - Data and analysis of the global vaccine production capacity as of 2010. Reasons to buy The report will help businessdevelopment and marketing executives strategize their product launches by doing the following - Build effective strategies by identifying the potential hotspots for vaccine manufacturing. - Develop key strategic initiatives by studying the portfolios of the top players. Table of Contents : 1.1 List of Tables 5 1.2 List of Figures 6 2 Manufacturing of Vaccines - Introduction 7 2.1 GBI Research Report Guidance 7 3 Manufacturing of Vaccines - Overview of Manufacturing 8 3.1 Upstream Bioprocessing 8 3.2 Downstream Bioprocessing 8 3.3 Methods for Producing Vaccines 8 3.3.1 Live Whole Virus Vaccines 9 3.3.2 Inactivated Whole Virus Vaccines 9 3.3.3 Subunit Vaccines 9 3.3.4 Recombinant Virus Vaccines 9
3.3.5 Egg-BasedVaccines 9 3.3.6 DNA Vaccines 9 3.4 Current Scenario of the Vaccine Manufacturing Industry 9 4 Manufacturing of Vaccines - Role of Manufacturing in the Vaccine Industry 10 4.1 Comparison of Manufacturing of Vaccines with Manufacturing of Biologics 10 4.2 Stakeholders for Manufacturing within the Company 11 4.2.1 R&D Division 11 4.2.2 Marketing Division 12 4.2.3 SalesDivision 12 4.2.4 Manufacturing Division 14 4.3 Stakeholders for Manufacturing within the Industry 15 4.3.1 Raw Material Suppliers 15 4.3.2 Packaging Suppliers 16 4.3.3 Distributors 17 5 Manufacturing of Vaccines - Vaccine Manufacturing Process19 5.1 Overview 19 For more Reports Plz follow The link: http://www.aarkstore.com/search/viewresults.asp?search=Cell Culture Technology&PubId=&pagenum=1
Gastrointestinal Disorder Therapeutics Market to 2017 - Crohns Diseaseand Irritable Bowel Syndrome Markets Show Strongest Growth Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries Immunoglobulins Market to 2017 - Off-Label Usageand Treatment of Primary Immunodeficiency Diseasesand Neurological Disorders Stimulate Market Growth Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline
Category Reports: Veterinary, Vaccines ,Stem Cell Research,Automobile, Aerospace& Aviation, Banking, Consumer Goods, Construction, Chemicals, Defense, Diabetes, Disease, Drinks, Energy, Electronics, Financial , Food & Drinks, Glass, Healthcare, Insurance, Information technology
For More details Plz do contact : Aarkstore Enterprise Phone:08149852585 Email: enquiry@aarkstore.com/ URL:www.aarkstore.com/